Mudan Yang

机构：Shanxi Provincial Cancer Hospital, Cancer Hospital of Chinese Academy of Medical Sciences

发表论文 16 篇 · 总被引 38 次 · h-index 4

代表论文

• Securinine inhibits carcinogenesis in gastric cancer by targeting AURKA-β-catenin/Akt/STAT3 and the cell cycle pathway (2024 · Phytomedicine · 被引 15)
• A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer (2024 · Med · 被引 8)
• [Clinicopathologic features and prognosis of 51 patients with α-fetoprotein-producing gastric cancer]. (2015 · PubMed · 被引 6)
• Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial (2026 · BMJ · 被引 4)
• KLF9‑regulated FBXO31 inhibits the progression of endometrial cancer and enhances the sensitivity of endometrial cancer cells to cisplatin (2023 · Experimental and Therapeutic Medicine · 被引 2)
• Assessment of efficacy of LBL-024, a novel and uniquely designed bispecific antibody against PD-L1 and 4-1BB, combined with etoposide/platinum-based chemotherapy in treatment-naive advanced extrapulmonary neuroendocrine carcinoma (EP-NEC): A multicenter phase Ib/II trial. (2025 · Journal of Clinical Oncology · 被引 1)